Quidel Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
175,410.00
182,615.00
196,129.00
191,603.00
277,743.00
522,285
Cost of Goods Sold (COGS) incl. D&A
75,876.00
83,918.00
79,932.00
82,002.00
121,681.00
206,572
Gross Income
99,534.00
98,697.00
116,197.00
109,601.00
156,062.00
315,713
SG&A Expense
92,964.00
105,257.00
112,847.00
113,555.00
130,084.00
204,473
EBIT
6,570.00
6,560.00
3,350.00
3,954.00
25,978.00
111,240
Unusual Expense
2,405.00
2,648.00
612.00
64.00
16,426.00
23,573
Non Operating Income/Expense
31.00
-
-
-
-
-
Interest Expense
777.00
1,775.00
12,035.00
12,181.00
17,588.00
24,283
Pretax Income
3,434.00
10,983.00
9,297.00
16,199.00
8,036.00
63,384
Income Tax
3,956.00
3,909.00
3,218.00
2,391.00
129.00
10,799
Consolidated Net Income
7,373.00
7,074.00
6,079.00
13,808.00
8,165.00
74,183
Net Income
7,373.00
7,074.00
6,079.00
13,808.00
8,165.00
74,183
Net Income After Extraordinaries
7,373.00
7,074.00
6,079.00
13,808.00
8,165.00
74,183
Net Income Available to Common
7,373.00
7,074.00
6,079.00
13,808.00
8,165.00
74,183
EPS (Basic)
0.21
0.21
0.18
0.42
0.24
1.86
Basic Shares Outstanding
33,836.00
34,451.00
34,104.00
32,708.00
33,734.00
37,995
EPS (Diluted)
0.21
0.21
0.18
0.42
0.24
1.86
Diluted Shares Outstanding
34,947.00
34,451.00
34,104.00
32,708.00
33,734.00
42,554
EBITDA
31,370.00
21,805.00
26,736.00
27,915.00
56,740.00
157,506
Non-Operating Interest Income
15.00
-
-
-
-
-
Other After Tax Income (Expense)
17.00
-
-
-
-
-

About Quidel

View Profile
Address
12544 High Bluff Drive
San Diego California 92130
United States
Employees -
Website http://www.quidel.com
Updated 07/08/2019
Quidel Corp. engages in the development, manufacture, and market of rapid diagnostic testing solutions. Its portfolio includes immunoassays, molecular diagnostics, virology, and specialty products. Immunoassay tests are for physician offices, hospital laboratories, emergency departments, pharmacies, and other urgent care or alternative site settings.